Group One Trading’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Group One Trading’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,980	Closed	-$54K	–	8743
2022 Q1	$54K	Sell	2,980 -20	-0.7%	-$378	﹤0.01%	6047
2021 Q4	$71K	Buy	+3,000	New	+$101K	﹤0.01%	6044

Other funds holding PHXM

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's PHXM Position: Q3 2023 in Review

Group One Trading sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2023, closing a stake of 1,059 shares — an estimated $7.73K sold.

Group One Trading first reported a position in PHXM in Q3 2021 and held it in 8 quarters. The position peaked at $25K in Q4 2021. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2023.

Group One Trading reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Group One Trading sold 1,059 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2023, an estimated $7.73K.
Group One Trading first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2021 and held it in 8 quarters.
Group One Trading's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $25K in Q4 2021.
3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.